PyInvesting

Market research

EXL.AU Elixinol Global Limited

AU AUD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
4M
P/E ratio
Not available
Analyst target
0.03
Dividend yield
Not available
Beta
2.21

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Elixinol Global Limited is currently in a long term downtrend where the price is trading 27.1% below its 200 day moving average.

From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.

Elixinol Global Limited's total revenue sank by 28.3% to $7M since the same quarter in the previous year.

Its net income has increased by 68.7% to $-23M since the same quarter in the previous year.

Finally, its free cash flow grew by 79.7% to $-4M since the same quarter in the previous year.

Based on the above factors, Elixinol Global Limited gets an overall score of 3/5.